Home › NDC Lookup › Ingredients › Clonazepam › 60760-0300-30
Clonazepam 1 mg Tablet, 30-count — NDC 60760-0300-30 package photo

Clonazepam 1 mg Tablet, 30-count

by St Marys Medical Park Pharmacy · 30 TABLET in 1 BOTTLE, PLASTIC (60760-300-30)
NDC 60760-0300-30
🏷️ FDA NDC (as labeled) 60760-300-30 billing pads the product segment with a zero
Rx only Generic On market CIV
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Clonazepam (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class I · Nov 18, 2024 — Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. (Endo USA, Inc.) · FDA recall D-0179-2025
Class I · Nov 18, 2024 — Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. (Endo USA, Inc.) · FDA recall D-0181-2025
Class I · Nov 18, 2024 — Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. (Endo USA, Inc.) · FDA recall D-0178-2025
Class I · Nov 18, 2024 — Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. (Endo USA, Inc.) · FDA recall D-0180-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 60760-300-30
Product NDC 60760-300
11-digit billing NDC 60760030030
NCPDP billing unit EA — each (per item)
RxCUI 197528
UNII 5PE9FDE8GB
Application # ANDA077147
SPL Set ID 31a7ed52-48a6-1c87-e054-00144ff88e88
Established class (EPC) Benzodiazepine
Chemical class Benzodiazepines
DEA schedule CIV
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-04-01
Route ORAL
Dosage form TABLET
Substance CLONAZEPAM
GPI-14 72100010000310
GPI class clonazePAM
GCN Seq No 004561
GCN 17471
HICL code 001894
Ingredient (HICL) Clonazepam
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H4
Therapeutic class — intermediate (HIC2) Anticonvulsants
HIC3 code H4A
Therapeutic class — specific (HIC3) Anticonvulsant - Benzodiazepine Type
AHFS code 28:12.08.00
AHFS class Benzodiazepines (Anticonvulsants)
FDB label name CLONAZEPAM 1 MG TABLET
FDB brand name Clonazepam
Legend status F — Federal legend — prescription drug or device
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 60760-300-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 60760-0300-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Benzodiazepine class.

Pharmacologic class Benzodiazepine
Drug family (ATC) Benzodiazepine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerSt Marys Medical Park Pharmacy
Application holderACCORD HEALTHCARE INC
FDA applicationANDA077147 (ANDA)
Labeler code60760
First marketedApr 2016
DEA scheduleCIV
Product typeHuman Prescription Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name CLONAZEPAM 1 MG TABLET Ingredient Clonazepam
📖 What it is MedlinePlus · NLM

Clonazepam is used to control certain types of seizures. It is also used to treat panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks). Clonazepam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Clonazepam is used for two main things: certain types of seizures and panic disorder. On the seizure side, it's approved for Lennox-Gastaut syndrome, akinetic seizures, myoclonic s...
  • It's a fair concern, and the honest answer is yes — clonazepam can cause physical dependence with regular use, and there is a real risk of misuse and addiction. This doesn't mean e...
  • Is it true clonazepam is addictive? Should I be worried?
  • Drowsiness is the big one — about half of people taking it for seizures experience it. Problems with balance or coordination (called ataxia) are also common. You might also notice...
📖 Read our full Clonazepam guide →
1
Nutrient depletion considerations

Clonazepam may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Clonazepam nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color blue
ShapeRound
ImprintC;1
Size8 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3SY5LH9PMK
    Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII L06K8R7DQK
    A synthetic blue dye approved by the FDA for use in medications and foods. It serves as a colorant to make pills and liquids visually distinct and easier to identify.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

6 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.0628 $1.88 / 30 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Clonazepam 1 mg 00093-3212-01 Teva 100 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 00904-7728-61 Major 100 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 16729-0137-00 Accord 100 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 43547-0407-10 Solco 100 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 50268-0174-15 AvPAK 50 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 59651-0723-01 Aurobindo 100 tablets $0.024 — Availability likely —
Clonazepam 1 mg 60687-0872-01 American 100 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 62135-0770-90 Chartwell 90 tablets $0.024 AB Availability likely —
Clonazepam 1 mg 72603-0308-01 Northstar 100 tablets $0.024 — Availability likely —
Clonazepam 1 mg 72888-0153-00 Advagen 1000 tablets $0.024 — Availability likely —
Klonopin 1 mg 61269-0610-10 H2-Pharma, 100 tablets $3.054 AB Availability likely —
Clonazepam 1 mg 43063-0794-30 PD-Rx 30 tablets — AB FDA listed —
Clonazepam 1 mg 50090-2022-00 A-S 60 tablets — AB Discontinued —
Clonazepam 1 mg 55154-4319-00 Cardinal 100 tablets — AB FDA listed —
Clonazepam 1 mg 58118-0153-08 Clinical 30 tablets — — FDA listed —
Clonazepam 1 mgthis 60760-0300-30 St 30 tablets — AB FDA listed —
Clonazepam 1 mg 63187-0888-30 Proficient 30 tablets — AB FDA listed —
Clonazepam 1 mg 63629-1116-01 Bryant 100 tablets — AB FDA listed —
Clonazepam 1 mg 63629-1204-01 Bryant 500 tablets — AB Discontinued —
Clonazepam 1 mg 63629-1205-01 Bryant 1000 tablets — AB FDA listed —
Clonazepam 1 mg 63629-8988-01 Bryant 30 tablets — AB FDA listed —
Clonazepam 1 mg 67046-0493-03 Coupler 30 tablets — AB FDA listed —
Clonazepam 1 mg 67046-0794-03 Coupler 30 tablets — AB FDA listed —
Clonazepam 1 mg 68071-5247-09 NuCare 90 tablets — AB FDA listed —
Clonazepam 1 mg 68788-8401-02 Preferred 20 tablets — AB FDA listed —
Clonazepam 1 mg 68788-8473-02 Preferred 20 tablets — — FDA listed —
Clonazepam 1 mg 70518-1521-01 REMEDYREPACK 100 tablets — AB FDA listed —
Clonazepam 1 mg 70518-2334-00 REMEDYREPACK 100 tablets — AB FDA listed —
Clonazepam 1 mg 70518-2533-00 REMEDYREPACK 30 tablets — AB Discontinued —
Clonazepam 1 mg 70518-3144-00 REMEDYREPACK 100 tablets — AB FDA listed —
Clonazepam 1 mg 70518-4074-00 REMEDYREPACK 30 tablets — AB FDA listed —
Clonazepam 1 mg 71205-0529-30 Proficient 30 tablets — AB FDA listed —
Clonazepam 1 mg 71335-0022-00 Bryant 100 tablets — AB FDA listed —
Clonazepam 1 mg 71335-1843-00 Bryant 100 tablets — AB FDA listed —
Clonazepam 1 mg 71335-2414-00 Bryant 100 tablets — — FDA listed —
Clonazepam 1 mg 71610-0040-30 Aphena 30 tablets — AB FDA listed —
Clonazepam 1 mg 71610-0771-15 Aphena 15 tablets — AB FDA listed —
Clonazepam 1 mg 71610-0852-12 Aphena 12 tablets — AB FDA listed —
Clonazepam 1 mg 72189-0475-30 Direct_Rx 30 tablets — AB FDA listed —
Clonazepam 1 mg 72789-0314-30 PD-Rx 30 tablets — AB FDA listed —
Clonazepam 1 mg 80425-0135-01 Advanced 30 tablets — AB FDA listed —
Clonazepam 1 mg 80425-0357-01 Advanced 30 tablets — AB FDA listed —
Clonazepam 1 mg 82804-0272-30 Proficient 30 tablets — AB FDA listed —
Clonazepam 1 mg 87441-0022-01 Unit 30 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2016
On the market since
Apr 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Clonazepam — the program that covers self-administered drugs. 10 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Clonazepam. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$15.53M
Claims incl. refills
2.1M
Beneficiaries
936.4K
Spend / beneficiary
$16.58
Spend / claim
$7.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Clonazepam — the ingredient across all brands.

Top reported reactions

Fatigue10,473
Nausea9,818
Anxiety8,896
Headache8,763
Depression8,232
Pain8,226
Dizziness7,402

Age at onset

Neonate212
Infant161
Child399
Adolescent334
Adult12,315
Elderly4,853

Reporter sex

0 reports

Serious outcomes

Hospitalization47,319
Death18,608
Life-threatening6,316
Disabling4,481
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 11,027 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
60760-0300-30 You're viewing this 30 TABLET in 1 BOTTLE, PLASTIC (60760-300-30) 2025-05-20 Active

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 60760-300-30, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 60760-0300-30, written without dashes as 60760030030. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 60760-0300-30, the first segment (60760) is the labeler code FDA assigned to St Marys Medical Park Pharmacy; the middle segment (0300) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (30) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by St Marys Medical Park Pharmacy. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
St Marys Medical Park Pharmacy is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings 🤒 Adverse Reactions 🆘 Overdosage 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling 💬 Medication Guide
🎯 Indications and Usage 3 words ▾

INDICATIONS AND USAGE

⏱️ Dosage and Administration 21 words ▾

DOSAGE AND ADMINISTRATION Clonazepam is available as a tablet. The tablets should be administered with water by swallowing the tablet whole.

⛔ Contraindications 50 words ▾

CONTRAINDICATIONS Clonazepam should not be used in patients with a history of sensitivity to benzodiazepines, nor in patients with clinical or biochemical evidence of significant liver disease. It may be used in patients with open angle glaucoma who are receiving appropriate therapy but is contraindicated in acute narrow angle glaucoma.

⚠️ Warnings 1 words ▾

WARNINGS

🤒 Adverse Reactions 19 words ▾

ADVERSE REACTIONS The adverse experiences for clonazepam are provided separately for patients with seizure disorders and with panic disorder.

🆘 Overdosage 1 words ▾

OVERDOSAGE

🧬 Clinical Pharmacology 2 words ▾

CLINICAL PHARMACOLOGY

📦 How Supplied / Storage and Handling 54 words ▾

HOW SUPPLIED Clonazepam tablets USP 1 mg are blue, round, flat faced, beveled edge, debossed with “C 1” on one side and plain on the other. They are supplied as follows: NDC: 60760-300-30 bottle of 30 Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature].

💬 Medication Guide ~3 min read ▾

Medication Guide Clonazepam Tablets, USP CIV Read this Medication Guide before you start taking clonazepam tablets and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.

Clonazepam tablets can cause serious side effects. Because stopping clonazepam tablets suddenly can also cause serious problems, do not stop taking clonazepam tablets without talking to your healthcare provider first. What is the most important information I should know about clonazepam tablets?

Do not stop taking clonazepam tablets without first talking to your healthcare provider. Stopping clonazepam tablets suddenly can cause serious problems. Clonazepam tablets can cause serious side effects, including: Clonazepam tablets can slow your thinking and motor skills Do not drive, operate heavy machinery, or do other dangerous activities until you know how clonazepam tablets affects you.

Do not drink alcohol or take other drugs that may make you sleepy or dizzy while taking clonazepam until you talk to your healthcare provider. When taken with alcohol or drugs that cause sleepiness or dizziness, clonazepam tablets may make your sleepiness or dizziness worse. Like other antiepileptic drugs, clonazepam tablets may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.

Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying attempt to commit suicide new or worse depression new or worse anxiety feeling agitated or restless panic attacks trouble sleeping (insomnia) new or worse irritability acting aggressive, being angry, or violent acting on dangerous impulses an extreme increase in activity and talking (mania) other unusual changes in behavior or mood How can I watch for early symptoms of suicidal thoughts and actions?

Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms.

Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes. Do not stop clonazepam tablets without first talking to a healthcare provider.

Stopping clonazepam tablets suddenly can cause serious problems. Stopping clonazepam tablets suddenly can cause seizures that will not stop (status epilepticus). Clonazepam tablets may harm your unborn or developing baby.

If you take clonazepam tablets during pregnancy, your baby is at risk for serious birth defects. These defects can happen as early as in the first month of pregnancy, even before you know you are pregnant. Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors.

Children born to mothers receiving benzodiazepine medications (including clonazepam tablets) late in pregnancy may be at some risk of experiencing breathing problems, feeding problems, hypothermia, and withdrawal symptoms. Tell your healthcare provider right away if you become pregnant while taking clonazepam tablets. You and your healthcare provider should decide if you will take clonazepam tablets while you are pregnant.

If you become pregnant while taking clonazepam tablets, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can register by calling 1-888-233-2334. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.

Clonazepam tablets can pass into breast milk. Talk to your healthcare provider about the best way to feed your baby if you take clonazepam tablets. You and your healthcare provider should decide if you wil…

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 60760-0298-15 · St. 60760-0306-10 · St →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.